Product How it works Pricing Blog FAQ About Contact
TEVA Pharmaceutical Industries

TEVA Pharmaceutical Industries (NYSE: TEVA) revenue

TEVA Pharmaceutical Industries reported revenue of $17,258m for fiscal 2025, 4.3% more than in fiscal 2024 ($16,544m). Since fiscal 2016 its revenue has fallen by 21.2%, an average decline of 2.6% a year.

TEVA Pharmaceutical Industries has grown its revenue for 3 years in a row, and its best year of the last 10 was fiscal 2016. The biggest drop was in fiscal 2018, −16.4%.

Revenue, in millions of US dollars21,903201621,853201718,271201816,887201916,659202015,878202114,925202215,846202316,544202417,2582025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$17,258m+4.3%$2,157m12.5%
2024$16,544m+4.4%−$303.0m−1.8%
2023$15,846m+6.2%$433.0m2.7%
2022$14,925m−6.0%−$2,197m−14.7%
2021$15,878m−4.7%$1,716m10.8%
2020$16,659m−1.4%−$3,572m−21.4%
2019$16,887m−7.6%−$443.0m−2.6%
2018$18,271m−16.4%−$1,637m−9.0%
2017$21,853m−0.2%−$17,484m−80.0%
2016$21,903m—$2,154m9.8%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

TEVA Pharmaceutical Industries revenue compared with its sector

By revenue for its latest fiscal year, TEVA Pharmaceutical Industries ranks 30th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; TEVA Pharmaceutical Industries, 4.3%.

RankCompanyRevenueRevenue growth
28thBoston Scientific$20,074m19.9%
29thUniversal Health Services$17,365m9.7%
30thTEVA Pharmaceutical Industries$17,258m4.3%
31stIQVIA$16,310m5.9%
32ndRegeneron Pharmaceuticals$14,343m1.0%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of TEVA Pharmaceutical Industries

How much revenue did TEVA Pharmaceutical Industries make in fiscal 2025?
TEVA Pharmaceutical Industries reported revenue of $17,258m for fiscal 2025, compared with $16,544m in fiscal 2024.
How much has the revenue of TEVA Pharmaceutical Industries fallen?
Between fiscal 2016 and fiscal 2025 it went from $21,903m to $17,258m: 21.2% less, an average decline of 2.6% a year.
What was the best year for revenue at TEVA Pharmaceutical Industries?
Of its last 10 fiscal years, fiscal 2016, with $21,903m.
Where does TEVA Pharmaceutical Industries rank in its sector by revenue?
It ranks 30th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for TEVA Pharmaceutical Industries come from?
From the annual report (Form 10-K) that TEVA Pharmaceutical Industries files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that TEVA Pharmaceutical Industries files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on TEVA Pharmaceutical Industries: the TEVA Pharmaceutical Industries page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.